Charting A Path To Deliver The COVID-19 Vaccine
This story is part of Science Friday’s coverage on the novel coronavirus, the agent of the disease COVID-19. Listen to experts discuss the spread, outbreak response, and treatment.
Last week, the United Kingdom approved a COVID-19 vaccine developed by Pfizer through an emergency authorization, and vaccinations began this week. There is still not an approved vaccine in the United States, but according to Operation Warp Speed, the federal government’s COVID-19 vaccine team, the goal is to produce and deliver 300 million doses by the end of January 2021.
Journalist Maryn McKenna and physician Uché Blackstock discuss how states and health departments are preparing to distribute the vaccine—and the hurdles they may face.
Uché Blackstock is a physician and founder of Advancing Health Equity in Brooklyn, New York.
Maryn McKenna is a science writer and columnist for Wired. She’s also the author of Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats.
Nirav Shah is director of the Maine Center for Disease Control and Prevention in Augusta, Maine.